THE POLYOL PATHWAY, SORBINIL, AND RENAL DYSFUNCTION

被引：44
作者：
BEYERMEARS, A [1 ]
机构：
[1] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT OPHTHALMOL,NEWARK,NJ 07103
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 1986年 / 35卷 / 04期
关键词：
D O I：
10.1016/0026-0495(86)90187-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：46 / 54
页数：9
相关论文
共 37 条
[1]  
ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[2]   URINARY-EXCRETION AND RENAL CLEARANCE OF SPECIFIC PLASMA-PROTEINS IN DIABETES OF SHORT AND LONG DURATION [J].
ARONOFF, SL ;
SCHNIDER, S ;
SMELTZER, J ;
MACKAY, W ;
TCHOU, P ;
RUSHFORTH, N ;
MILLER, M ;
BENNETT, PH .
DIABETES, 1981, 30 (08) :656-663
[3]  
BAUDOIN C, 1983, DIABETES, V32, P8, DOI 10.2337/diab.32.2.S8
[4]   SORBINIL PROTECTION OF LENS PROTEIN-COMPONENTS AND CELL HYDRATION DURING DIABETIC CATARACT FORMATION [J].
BEYERMEARS, A ;
CRUZ, E ;
NICOLASALEXANDRE, J ;
VARAGIANNIS, E .
PHARMACOLOGY, 1982, 24 (03) :193-200
[5]   SYNERGISM OF SORBINIL AND NORMAL DIET ON REVERSAL OF STAGE-II SUGAR CATARACT [J].
BEYERMEARS, A ;
KELLY, K ;
CRUZ, E .
PHARMACOLOGY, 1985, 31 (03) :170-179
[6]   REVERSAL OF STAGE-I SUGAR CATARACT BY SORBINIL, AN ALDOSE REDUCTASE INHIBITOR [J].
BEYERMEARS, A ;
CRUZ, E ;
VARAGIANNIS, E .
PHARMACOLOGY, 1985, 31 (02) :88-96
[7]  
BEYERMEARS A, 1982, ARCH INT PHARMACOD T, V259, P166
[8]   GLOMERULAR POLYOL ACCUMULATION IN DIABETES AND ITS PREVENTION BY ORAL SORBINIL [J].
BEYERMEARS, A ;
KU, L ;
COHEN, MP .
DIABETES, 1984, 33 (06) :604-607
[9]   REVERSAL OF DIABETIC CATARACT BY SORBINIL, AN ALDOSE REDUCTASE INHIBITOR [J].
BEYERMEARS, A ;
CRUZ, E .
DIABETES, 1985, 34 (01) :15-21
[10]  
BEYERMEARS A, 1979, EXP EYE RES, P709
1234